10. Correas JM, Claudon M, Tranquart F et al. Correspondence and offprint requests to: Nurhan Seyahi; E-mail: nseyahi@yahoo.com Abstract Background. Cardiovascular disease is the leading cause of mortality among renal transplant recipients. Data on the relationship between coronary artery calcification (CAC) and coronary ischaemia in renal transplantation patients are scant. We conducted a study to determine the prevalence and determinants of CAC in these patients; we also examined the frequency of coronary ischaemia in patients with moderate and severe CAC. Methods. We used multi-detector spiral computed tomography to examine CAC in 178 consecutive renal transplant recipients. Angina pectoris was sought with the Rose questionnaire. The extent of calcification was measured by Agatston score. Myocardial perfusion scintigraphy was performed in patients with moderate and severe CAC. Multivariate logistic and linear regression analysis was used to evaluate the determinants of CAC presence and CAC score, respectively. Results. CAC was present in 72 patients (40.4%), mean CAC score was 113.7 ± 275.5 (median: 0 and range: 0-1712). Age, time on transplantation and Rose angina pectoris were the independent determinants of both CAC presence and high CAC scores in all multivariate models. Coronary ischaemia was detected in 17.1% of the patients with moderate-to-severe CAC. Conclusions. CAC is highly prevalent in renal transplant recipients; it is associated with symptoms of coronary ischaemia. Time on transplantation is an independent determinant of CAC. Future studies to evaluate the prognostic significance of CAC in these patients are necessary.
Introduction
Epidemiologic data depict a tight link between chronic kidney disease and cardiovascular disease [1] [2] [3] . Even a slight reduction in glomerular filtration rate (GFR) is associated with a significant increase in cardiovascular risk [3] . Cardiovascular disease is the leading cause of mortality among renal transplant recipients [4, 5] .
In the general population, the presence of coronary artery calcification (CAC) identifies the presence of coronary artery atherosclerosis, symptoms of coronary ischaemia and relative risk for cardiovascular events that increases with increased CAC scores [6] [7] [8] [9] [10] [11] . However, until recently, data on the prevalence, severity and importance of CAC in renal transplant recipients were not extensively studied [12] [13] [14] [15] [16] [17] [18] [19] . Moreover, data on the relationship between CAC, symptoms of coronary ischaemia and coronary artery disease in renal transplantation recipients are missing. We conducted a study to determine the prevalence and determinants of CAC in these patients. We also examined the frequency of coronary ischaemia in a subgroup of patients with moderateto-severe CAC.
Materials and methods

Subjects
Between March 2006 and December 2007, we examined consecutive renal transplant recipients, who were followed up in our outpatient renal transplantation clinic. Only adult patients (≥18 years of age), who had given informed consent were recruited into the study. Pregnant patients, patients with malignancy or patients in whom time on transplantation is less than 3 months were excluded from the study. We wanted to examine the relationship between coronary ischaemia and CAC; therefore, we did not exclude the patients based on the history of coronary artery disease, presence of cardiovascular symptoms or cardiovascular disease risk factors. However, one patient, who had an extremely high CAC score (7834) and history of coronary stenting, was excluded from the analysis.
Standard immunosuppressive protocol consisted of induction therapy with rabbit anti-thymocyte globulin (in cadaveric transplantations) or basiliximab (in high-risk living transplantations), followed by maintenance therapy with a calcineurin inhibitor (tacrolimus or cyclosporine), mycophenolate mofetil or mycophenolate sodium, and low-dose prednisolone (5 mg/day).
Protocol
The date of the clinical evaluation was accepted as the enrolment date to the study. Laboratory tests and multi-detector spiral computed tomography (MDCT) scans were performed within 2 weeks of enrolment. According to previous data [7, 8] , a CAC score >100 is associated with an increased risk of myocardial ischaemia. Myocardial perfusion scintigraphy (MPS) was performed selectively only in patients with a CAC score >100. MPS examinations were performed within 2 months of enrolment.
Data on history of coronary artery disease were collected from patient files and with interviews. Angina pectoris was sought by a physician using Rose questionnaire [20] . Family history of cardiovascular disease was defined as having a first degree relative, who had a myocardial infarction or stroke before the age of 55 years in males or before the age of 65 years in females. Blood pressure was determined as the average of two measurements obtained 5 min apart after subjects had rested quietly in the supine position for 10 min. Subjects with a systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg, or receiving medication for treatment of hypertension were defined as hypertensive. Patients with fasting glucose ≥126 mg/dL (7 mmol/L), and/or receiving oral hypoglycaemic or insulin treatment for diabetes were defined as diabetic. Dyslipidaemia was defined according to the cut-off values suggested by the national cholesterol education programme, adult treatment panel III [21] . Selected patients were enrolled for the follow-up phase of the study. In this paper, we report the results of all the patients who were examined in the cross-sectional phase.
The study protocol was approved by the local medical ethics committee (protocol number: 18578).
Laboratory assessment
Blood was collected after an overnight fast for the measurement of creatinine, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, calcium, phosphorus, parathormone and C-reactive protein (CRP). Urinary albumin excretion was measured in urine samples collected for 24 h. Microalbuminuria was defined by urinary albumin excretion ≥30 mg/24 h and overt proteinuria by urinary albumin excretion ≥300 mg/24 h. Parathormone levels were determined by means of chemiluminescence immunoassay (Liaison N-tact; DiaSorin Inc, Stillwater, MN, USA), and CRP values were measured using a nephelometer (Behring BN II; Dade Behring, Deerfiled, IL, USA). All the remaining laboratory parameters were measured using Abbott Architect c8000 autoanalyser (Abbott Diagnostics, Abbott Park, IL, USA).
GFR was estimated using the abbreviated Modification of Diet in Renal Disease (MDRD) Study equation [22] .
Imaging procedures
All subjects underwent MDCT imaging with a SOMATOM Sensation 16 Cardiac system (Siemens AG, Erlangen, Germany). The data acquisition parameters were as follows: 120 kV, 133 mAs, slice collimation 1.5 mm, slice width 3.0 mm, rotation time 0.42 s and table feed 5.6 mm. Thirty to 40 slices were obtained during single breath-holding periods. Images were reconstructed with retrospective electrocardiogram gating to a 512-pixel matrix using a medium body filter. All images were examined preliminarily by one of the two expert technicians and over-read by a single radiologist blinded to clinical data. CAC scores were calculated according to the Agatston method [23] , using syngo VB 10B (Siemens AG, Erlangen, Germany) software. The presence of CAC was defined by a CAC score of ≥1.
In patients with a CAC score >100, myocardial perfusion scintigraphy was performed. Stress was induced by symptom-limited treadmill exercise (Bruce protocol), or in patients who cannot exercise adequately, by dipyridamole injection (30 mg infused intravenously over 4 min). Depending on the availability of the radiopharmaceutical agent, a Tc-99m MIBI scan (12 mCI before stress imaging and 25 mCI before rest imaging) or a Tal-201 scan (3 mCI before stress imaging and 1 mCI before rest imaging) was performed. Myocardial perfusion was assessed by examining shortaxis, vertical long-axis and horizontal long-axis images.
Statistical analysis
Data are expressed as mean ± standard deviation, if not stated otherwise. Categorical variables were compared using chi-square or Fisher exact test, when appropriate. Continuous variables were first analysed for normality by examining histograms and normal Q-Q plots, and then compared with using Student's t-test or Mann-Whitney U-test, when appropriate.
Age-adjusted odds ratios were obtained with the use of logistic or linear regression models. Association between CAC score and continuous variables was evaluated by means of Pearson's correlation. Association between categorical variables and CAC score was evaluated by means of Mann-Whitney U-test, using the categorical variable as the grouping variable. Distribution of CAC scores was non-normal; therefore, correlation tests and linear regression analyses between CAC score and continuous variables were performed using log-transformed [ln (1 + absolute CAC score)] CAC scores [24] . Distribution of the following variablesage, time on transplantation, dialysis vintage, amount of smoking, BMI, lipid parameters, CRP, PTH and albuminuria-was also non-normal (mostly right skewed); therefore, a log transformation was performed before correlation and linear regression tests. Variables that have a minimum value of zero were log-transformed using 1 + absolute variable value; otherwise, log transformation was performed based on the absolute value of the variable. Multivariate logistic and linear regression analysis was used to evaluate the determinants of CAC presence and CAC score, respectively. Forward selection was used in multivariate models.
All tests were performed using SPSS for Windows, version 15.0, software (SPSS Inc, Chicago, IL, USA). Figures were prepared using Microsoft ® Office Excel © 2007 software (Microsoft Corp., Redmond, WA, USA). P-value >0.05 is considered statistically significant.
Results
Demographic characteristics, cardiovascular risk factors and laboratory data
The demographic characteristics, and clinical and laboratory data for the 178 renal transplant recipients are listed in Table 1 . Study participants were predominantly male and mostly young or middle aged, and they had a living donor transplant (Table 1) . Pre-emptive transplantation was performed in three (1.7%) patients. History of previous coronary artery disease was present in four patients (2.2%). Rose questionnaire angina pectoris was reported by 13 (7.3%) patients, and all the patients with previous history of coronary artery disease were reported to have angina pectoris.
Nearly half of the subjects had a history of smoking (Table 1) . However, prevalence of active smokers was low (6.2%). According to BMI, 37.1% of the patients were overweight (BMI >25), and 14.6% were obese (BMI >30). The majority of the patients had hypertension; however, systolic and diastolic blood pressure levels were generally within normal limits ( Table 1 ). The prevalence of diabetes was low (Table 1) , and only one patient was diabetic before the transplantation. Dyslipidaemia was highly prevalent, and 78.1% of the patients had at least one type of lipid abnormality or were taking lipid-lowering medications.
GFR was >30 mL/min/1.73 m 2 in 93.8% of the patients, microalbuminuria was present in 40.4% and overt proteinuria was present in 19.7% of the patients. Calcium and phosphorus levels were generally within the normal range of the laboratory; however, PTH levels were high (upper limit for laboratory 72 pg/mL) in 54.5% of the patients.
Aspirin was used by 16.3%, statins by 41.0%, antihypertensive medications by 77.5%, biphosphanates by 19.1%, calcium supplements by 29.2% and vitamin D supplements by 25.8% of the patients.
Coronary artery calcification
CAC was present in 72 patients (40.4%), and mean CAC score was 113.7 ± 275.5 (median: 0 and range: 0-1712). Distribution of CAC scores among patients is shown in Figure 1 . A CAC score >100 indicates moderate calcification, and 16 patients (9%) had a CAC score >100. A CAC score > 400 indicates severe calcification, and 20 patients (11.2%) had a calcification score >400.
Determinants of coronary artery calcification
The association between CAC and various study parameters was first evaluated by univariate analysis. Characteristics of renal transplant recipients, according to presence or absence of coronary artery calcification, are shown in Table 2 . Based on univariate analysis, higher donor age, longer time on transplantation, presence of Rose angina pectoris, greater amount of smoking, presence of diabetes mellitus and higher systolic blood pressure were associated with CAC (Table 2 ). Previous studies show that age is one of the most important determinants of CAC in the general population and in various patient groups including renal transplantation patients [13, 15, 18, [25] [26] [27] [28] . Therefore, we analysed the association between CAC and study parameters using age as a covariate in a logistic regression model. According to age-adjusted analysis, time on transplantation, dialysis vintage and rose angina pectoris were associated with CAC (Table 3) .
Finally, we constructed two multivariate logistic regression models; in the first model, variables that were significantly associated with CAC based on univariate analysis were used, and in the second model, variables that were associated with CAC based on age-adjusted analysis were used. In both models, age, time on transplantation and Rose angina pectoris were determinants of CAC; moreover, according to the second model, dialysis vintage was another determinant of CAC (Table 3) .
Determinants of coronary artery calcification score
Study parameters that were significantly associated with CAC score were shown in Table 4 . Variables that were significantly associated with CAC score based on age-adjusted analysis were also shown in Table 4 .
We constructed two multivariate linear regression models; in the first model, variables that were significantly associated with CAC score based on univariate analysis were used, and in the second model, variables were selected according to age-adjusted analysis. Age, time on transplantation and Rose angina pectoris were significantly associated with CAC score in both models. Addition- In the first multivariate model, variables were selected based on univariate analysis, and in the second one, variables were selected based on ageadjusted analysis. CI, confidence interval.
ally, in the second model, there was a negative association between LDL cholesterol levels, and a positive association with diabetes mellitus and CAC score (Table 4) . We controlled for statin use, and the negative association with LDL cholesterol was still significant (data not shown). The use of aspirin, statins, antihypertensive medications, biphosphanates, calcium supplements and vitamin D supplements was not associated with CAC and CAC score (data not shown).
Coronary ischaemia and coronary artery calcification score
MPS was performed in 35 (27 M/8 F; mean age: 43.6 ± 11.6 years; post-transplant duration: 120.9 ± 75.6 months) of the 36 patients with a CAC score >100. One remaining patient, with severe coronary artery calcification, had a ventricular tachycardia attack during the MPS. The procedure could not be completed subsequently, and a coronary angiography was performed. He had a history of coronary artery bypass grafting, and the new coronary angiography revealed multiple stenoses in left main coronary artery, in the left descending coronary artery and in the grafts. We excluded the patient, who did not have an MPS, from the following analysis. The results of the remaining patients were shown in Figure 2 . Overall, coronary ischaemia was detected in 6 (17.1%) of the 35 patients. Four of these six patients did not have a history or have symptoms of cardiovascular disease. The prevalence of coronary ischaemia of the patients with severe CAC was higher compared with that of the patients with moderate CAC; however, this difference was not statistically significant ( Figure 2 ; P = 0.187). CAC scores of the patients with coronary ischaemia (622.3 ± 214.0) were not statistically different than that of the patients without coronary ischaemia (504.7 ± 415.4) (P = 0.178).
Discussion
We examined a fairly large number of renal transplant recipients and found that CAC was prevalent and severe in these patients. To the best of our knowledge, this is the largest study that examines CAC in renal transplant recipients and the first one that addresses the relation between CAC and coronary ischaemia in these patients.
In previous studies [12] [13] [14] [15] [16] [17] [18] , the prevalence of CAC was found between 38% and 67.1%. In line with this data, we also found a high prevalence of CAC in our relatively younger renal transplant recipients.
The association of CAC with age is well known and is reported in different groups including dialysis and transplantation patients, and our results are in line with this data [13, 15, 18, [29] [30] [31] [32] .
Diabetes is an established risk factor for coronary heart disease [33] and was associated with CAC in renal transplant recipients [13] . Despite the small number of patients with diabetes mellitus, we also found diabetes as a determinant of high CAC scores.
Paradoxically, there was a reverse relationship between LDL cholesterol and CAC scores. Interestingly, a similar finding was reported in renal transplant patients by Bargnoux et al. [18] . Such associations were previously defined in ESRD patients and described as 'reverse epidemiology' [34] . However, in some cases, reversal back to traditional epidemiology has been described after a successful renal transplantation [34] . We controlled for statin use, and the negative association was still significant, but cholesterol levels can also be influenced by different immunosuppressive drugs. Besides, unfortunately, we did not collect more robust data on lipid-lowering medications, such as daily and cumulative doses and adherence to therapy. Therefore, we cannot rule out the possibility of residual confounding. Similar to our results, previous studies in renal transplant patients did not find a significant association between baseline CAC and mineral metabolism parameters [13, 18] . On the other hand, according to a recent study, hyperparathyroidism was linked to progression of CAC after transplantation [17] .
The independent association of CAC and CAC score with time on transplantation possibly reflects the progression of CAC in renal transplant recipients. The progression of CAC in renal transplantation recipients was studied in a couple of studies [12, 14, [16] [17] [18] [19] . In a few studies, conflicting results were obtained; it was not clear whether the progression of CAC slows down or reverses following renal transplantation. Only one of these studies used a control group, and that study also had the longest (2 years) follow-up time [17] . The authors concluded that renal transplantation slows down but does not halt CAC progression.
CAC that is detected in atherosclerotic plaques affects the intimal layer of the arteries [30] . In patients with end-stage renal disease, the extent of arterial calcification represents the aggregate of both atherosclerotic and medial wall calcification. The combined impact of both processes may contribute to the very high rates of cardiovascular calcification in these patients. Computed tomography cannot differentiate between intimal and medial calcification, and some [31] but not all [32] studies have shown a correlation between CAC and coronary atherosclerosis in ESRD patients. It can be suggested that the high rates of CAC in the kidney transplant patients, at least partially, reflect a medial calcification burden, accumulated during the dialysis period. Indeed, in our study, dialysis vintage was an independent determinant of CAC, and similar results were previously reported [12, 18, 19] .
To the best of our knowledge, the association between Rose angina pectoris and CAC was not previously examined in renal transplant recipients. In the general population, several studies have shown that the diagnosis of angina pectoris, based on the Rose questionnaire, predicts coronary heart disease morbidity and mortality [35] [36] [37] . In the general population, Rose questionnaire angina pectoris is strongly associated with CAC, in both males and females, and the odds ratio for having a high CAC score was found (12.9 for men and 4.8 for women) [11] . We also calculated a high odds ratio (7.6, 95% CI 1.8-31.9) for having CAC in patients with angina pectoris. Additionally, there was a trend towards higher rates of coronary ischaemia by MPS in patients with severe CAC, compared with patients with moderate CAC. However, in this subgroup analysis, we examined a relatively small number of patients, and this association was not statistically significant. These data might suggest that, at least in patients with coronary ischaemia, intimal calcification can be an important contributor of total calcification burden, and the prognostic implications of CAC might be different in these patients.
Previous studies performed in much older (mean age: 58-61 years) subjects selected from the general population showed that the risk for coronary ischaemia increased above a CAC score threshold of 100 [8] or 400 [7, 38] . In these studies, the prevalence of silent myocardial ischaemia by scintigraphy was found to be between 10.4% and 46% in patients who have a coronary artery calcification score >400 [7, 8, 38] . CAC scores are higher in renal transplant recipients, and therefore, despite their younger age, possibly a high (>400) CAC score cut-off level should be used before screening for myocardial ischaemia especially in asymptomatic patients. Below this level, the prevalence of myocardial ischaemia seems to be low.
There is an ongoing debate on the use of CAC scoring as a screening tool [39] . Our study supports a minor role for CAC in predicting silent ischaemia in renal transplant recipients. However, transplant patients with normal MPS and high CAC scores might still have an increased risk for cardiac events. Indeed, a very important question is whether CAC was associated with cardiovascular and general mortality in renal transplant recipients. There is no definite answer to this question yet. According to a recent study by DeLoach et al., aortic calcification predicts cardiovascular events and all-cause mortality in renal transplantation [40] .
Our study also has some weaknesses. Cross-sectional nature is an important limitation; it is very hard to infer causality. Obviously, a longitudinal study can provide better data to assess the risk factors associated with the progression of CAC. To fully describe the relationship between CAC and coronary ischaemia, MPS would have to be performed in all patients. However, MPS was performed only in patients with moderate-to-severe CAC, based on previous data that were derived mainly from the non-transplant population. A semi-quantitative scoring was not used during the interpretation of MPS. Finally, the number of diabetics was relatively small, and generalizability of our results can be limited. In our clinic, kidney transplantation is mainly performed from living donors, and usually, our diabetic patients with multiple comorbidities were not good candidates for living donor transplantation. Therefore, this relatively low number of diabetics reflects centre policy rather than selection bias.
In conclusion, CAC is highly prevalent and severe in renal transplant recipients. Time on transplantation is an independent determinant for both CAC presence and CAC score. CAC is associated with symptoms of coronary ischaemia; and there is a trend towards higher rates of coronary ischaemia by MPS in patients with severe CAC. There are as yet no available data on the risk for cardiac events among renal transplant patients with high CAC scores. Future studies to evaluate the prognostic significance of CAC are necessary.
